<SEC-DOCUMENT>0000318154-24-000027-index.html : 20240621 <SEC-HEADER>0000318154-24-000027.hdr.sgml : 20240621 <ACCEPTANCE-DATETIME>20240620192023 ACCESSION NUMBER: 0000318154-24-000027 CONFORMED SUBMISSION TYPE: 11-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240621 DATE AS OF CHANGE: 20240620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 11-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37702 FILM NUMBER: 241058008 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 </SEC-HEADER> <DOCUMENT> <TYPE>11-K <SEQUENCE>1 <FILENAME>a2023puertoricoplan11-k.htm <DESCRIPTION>2023 PUERTO RICO PLAN 11-K <TEXT> Document 1 - file: a2023puertoricoplan11-k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>2 <FILENAME>amgn-ex231_20231231xpr.htm <DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM <TEXT> Document 2 - file: amgn-ex231_20231231xpr.htm
</DOCUMENT> </SEC-DOCUMENT>